Vaxinia MAST Trial:
47 heavily pre-treated patients have been dosed to date (24 April 2024), of which 40 patients are evaluable meaning they received at least their first scan at day 42
• Nearly half of the evaluable patients (48%) have remained on treatment for more than 3 months, representing significant disease control; 3 monotherapy patients have remained on treatment for over 200 days
perhaps a new update soon ?
onCARlytics OASIS Trial:
Preliminary early combination data are expected in the fourth quarter of 2024.
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-16
-
- There are more pages in this discussion • 104 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $379.2M | |||
| Open | High | Low | Value | Volume |
| 5.2¢ | 5.2¢ | 5.1¢ | $725.9K | 14.18M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 31 | 4606426 | 5.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.2¢ | 5573738 | 37 |
View Market Depth
| Last trade - 15.44pm 13/09/2024 (20 minute delay) ? |
| IMU (ASX) Chart |